Premanand Maharaj is facing a serious kidney problem, admitting both his kidneys have failed and he is undergoing dialysis.

The FDA has granted Fast Track designation to ABBV-CLS-628 for the treatment of autosomal dominant polycystic kidney disease.

XORTX Therapeutics Inc. (“XORTX ” or the “Company ”) (NASDAQ: XRTX \| TSXV: XRTX \| Frankfurt: ANU), a late stage clinica ...

Premanand Ji Maharaj, a revered spiritual leader from Vrindavan, has been living with complete kidney failure for nearly two ...

Del Webb's Karyn and Jerry Waxman are hosting the PKD Applied Underwriters Invitational on Oct. 27 at Lakewood National Golf ...

Food and Drug Administration grants rolling review of Biologics License Application for povetacicept in IgA nephropathy; Vertex to submit first module before end of year -- Second pivotal development ...

A video of a Muslim man is currently going viral on social media, touching the hearts of devotees of Premanand Maharaj and ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its third quarter 2025 financial results on Monday, November 3 ...

AbbVie's strong results, pipeline wins, and Rinvoq exclusivity boost its outlook. Read the latest analysis on ABBV stock here.

In December last year, John Pengelly’s story made local and national news. The former army captain, of Bradford, was an ...

In August 2025, Arif Khan Chishti, a 26-year-old Muslim youth from Narmadapuram, Madhya Pradesh, offered to donate one of his kidneys to the saint, who is suffering from autosomal dominant polycystic ...